Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Historical mysteries solved by science in 2025 - 24 Electric Vehicle Brands: Execution, Unwavering quality, and Development
- 3Wedding trip Objections in the US
- 4Geomagnetic storm grounds launch of Mars space weather satellites
- 5The Golden Globes gift bag has nearly $1 million worth of swag for some winners and presenters. What's in it?
- Drenched in Pixels: A Survey of \Vivid Interactivity Experience\ Game
- Pick Your Number one Sort Of Music
- Find the Specialty of Calligraphy: Dominating the Exquisite Art of Penmanship
- Discovering a sense of harmony: Individual Accounts of Reflection and Care
- Fundamental Home Machines: An Easy to understand Determination Guide
- Top Smoothie Flavor: What's Your Mix?
- 4 Energy-Proficient Clothes washers to Consider in 2024
- Kansas school officials report high student illness, dismiss early
- The most effective method to Pick the Right Teeth Substitution Choice for You
